These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 21477419

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Changes in illness-related cognitions rather than distress mediate improvements in irritable bowel syndrome (IBS) symptoms and disability following a brief cognitive behavioural therapy intervention.
    Chilcot J, Moss-Morris R.
    Behav Res Ther; 2013 Oct; 51(10):690-5. PubMed ID: 23948131
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of cognitive behaviour therapy in addition to mebeverine for irritable bowel syndrome.
    McCrone P, Knapp M, Kennedy T, Seed P, Jones R, Darnley S, Chalder T.
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):255-63. PubMed ID: 18334867
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.
    Lee KJ, Kim NY, Kwon JK, Huh KC, Lee OY, Lee JS, Choi SC, Sohn CI, Myung SJ, Park HJ, Choi MK, Bak YT, Rhee PL.
    Neurogastroenterol Motil; 2011 Dec; 23(12):1098-104. PubMed ID: 21920001
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Key mechanisms of cognitive behavioural therapy in irritable bowel syndrome: The importance of gastrointestinal related cognitions, behaviours and general anxiety.
    Windgassen S, Moss-Morris R, Goldsmith K, Chalder T.
    J Psychosom Res; 2019 Mar; 118():73-82. PubMed ID: 30522750
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effects of cognitive behavioral therapy in female nursing students with irritable bowel syndrome: a randomized trial.
    Jang AL, Hwang SK, Kim DU.
    Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):918-26. PubMed ID: 24999797
    [Abstract] [Full Text] [Related]

  • 14. A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care.
    Moss-Morris R, McAlpine L, Didsbury LP, Spence MJ.
    Psychol Med; 2010 Jan; 40(1):85-94. PubMed ID: 19531276
    [Abstract] [Full Text] [Related]

  • 15. Predictors of outcome in cognitive and behavioural interventions for irritable bowel syndrome. A meta-analysis.
    Radu M, Moldovan R, Pintea S, Băban A, Dumitrascu D.
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):257-263. PubMed ID: 30240469
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website.
    Everitt H, Moss-Morris R, Sibelli A, Tapp L, Coleman N, Yardley L, Smith P, Little P.
    BMC Gastroenterol; 2013 Apr 21; 13():68. PubMed ID: 23602047
    [Abstract] [Full Text] [Related]

  • 20. A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study.
    Chapman ND, Grillage MG, Mazumder R, Atkinson SN.
    Br J Clin Pract; 1990 Nov 21; 44(11):461-6. PubMed ID: 2177997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.